Literature DB >> 27428754

Is the regulation of SIRT1 by miRNA-34a the key to mesenchymal stem cell survival?

Michael A Bellio1, Wayne Balkan1, Joshua M Hare1, Ivonne Hernandez Schulman2.   

Abstract

Entities:  

Year:  2016        PMID： 27428754      PMCID： PMC4930520          DOI： 10.21037/atm.2016.05.45

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart.

Authors:  Sashwati Roy; Savita Khanna; William A Wallace; Jani Lappalainen; Cameron Rink; Arturo J Cardounel; Jay L Zweier; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

2.  Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.

Authors:  Laisheng Li; Xinhua Xie; Jinmei Luo; Min Liu; Shaoyan Xi; Jiaoli Guo; Yanan Kong; Minqing Wu; Jie Gao; Zeming Xie; Jun Tang; Xi Wang; Weidong Wei; Mingtian Yang; Mien-Chie Hung; Xiaoming Xie
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

3.  Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.

Authors:  Jian-Jun Chen; Sheng-Hua Zhou
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

Review 4.  Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration.

Authors:  Rosemeire M Kanashiro-Takeuchi; Ivonne Hernandez Schulman; Joshua M Hare
Journal:  J Mol Cell Cardiol       Date:  2011-05-30       Impact factor: 5.000

5.  Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?

Authors:  Cristina Sanina; Joshua M Hare
Journal:  Circ Res       Date:  2015-07-17       Impact factor: 17.367

6.  Over-expression of VEGF in marrow stromal cells promotes angiogenesis in rats with cerebral infarction via the synergistic effects of VEGF and Ang-2.

Authors:  Tianbao Lai; Man Li; Lifang Zheng; Yanling Song; Xiaoli Xu; Yuanjin Guo; Yuan Zhang; Zongsheng Zhang; Yuanwu Mei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

7.  S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells.

Authors:  Samirah A Gomes; Erika B Rangel; Courtney Premer; Raul A Dulce; Yenong Cao; Victoria Florea; Wayne Balkan; Claudia O Rodrigues; Andrew V Schally; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-03       Impact factor: 11.205

Review 8.  Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.

Authors:  Samuel Golpanian; Ivonne H Schulman; Ray F Ebert; Alan W Heldman; Darcy L DiFede; Phillip C Yang; Joseph C Wu; Roberto Bolli; Emerson C Perin; Lem Moyé; Robert D Simari; Ariel Wolf; Joshua M Hare
Journal:  Stem Cells Transl Med       Date:  2015-12-18       Impact factor: 6.940

9.  Myocardial protective effect of extracellular superoxide dismutase gene modified bone marrow mesenchymal stromal cells on infarcted mice hearts.

Authors:  Qiao Pan; Xing Qin; Sai Ma; Haichang Wang; Kang Cheng; Xinxing Song; Haokao Gao; Qiang Wang; Rannie Tao; Yabin Wang; Xiujuan Li; Lize Xiong; Feng Cao
Journal:  Theranostics       Date:  2014-02-15       Impact factor: 11.556

Review 10.  Mir-34: a new weapon against cancer?

Authors:  Gabriella Misso; Maria Teresa Di Martino; Giuseppe De Rosa; Ammad Ahmad Farooqi; Angela Lombardi; Virginia Campani; Mayra Rachele Zarone; Annamaria Gullà; Pierosandro Tagliaferri; Pierfrancesco Tassone; Michele Caraglia
Journal:  Mol Ther Nucleic Acids       Date:  2014-09-23       Impact factor: 10.183
View more
  1 in total

1.  Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells.

Authors:  Xu Zhu; Xiaomeng Shen; Jun Qu; Robert M Straubinger; William J Jusko
Journal:  Front Pharmacol       Date:  2018-02-19       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.